| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.41B | +37.3% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥-0.02B | — |
| Net income | ¥-0.02B | — |
| Gross margin | 24.2% | Net margin -4.2% |
| Revenue Q/Q | -52.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.31B | 75.8% |
| R&D | ¥0.02B | 5.7% |
| SG&A | ¥0.11B | 26.7% |
| Tax & other | ¥0.00B | 0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
和顺科技 ・ 瑞泰新材 ・ 普瑞眼科 ・ 宏源药业 ・ 杰创智能 ・ 威尔高 ・ 同星科技 ・ 通力科技 ・ 华融化学 ・ 普蕊斯 ・ 富士莱 ・ 艾布鲁
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies